Share

April 27, 2004; 62 (8) Special Articles

Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy

Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

J. A. French, A. M. Kanner, J. Bautista, B. Abou-Khalil, T. Browne, C. L. Harden, W. H. Theodore, C. Bazil, J. Stern, S. C. Schachter, D. Bergen, D. Hirtz, G. D. Montouris, M. Nespeca, B. Gidal, W. J. Marks, W. R. Turk, J. H. Fischer, B. Bourgeois, A. Wilner, R. E. Faught, R. C. Sachdeo, A. Beydoun, T. A. Glauser
First published April 26, 2004, DOI: https://doi.org/10.1212/01.WNL.0000123695.22623.32
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
66453

Share

Article Information

vol. 62 no. 8 1261-1273
DOI: 
https://doi.org/10.1212/01.WNL.0000123695.22623.32
PubMed: 
15111660
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received September 3, 2003
  • Accepted January 24, 2004
  • First Published April 26, 2004.
Copyright & Usage: 
© 2004

Author Disclosures

    1. J. A. French, MD*,
    2. A. M. Kanner, MD†,
    3. J. Bautista, MD,
    4. B. Abou-Khalil, MD,
    5. T. Browne, MD,
    6. C. L. Harden, MD,
    7. W. H. Theodore, MD,
    8. C. Bazil, MD PhD,
    9. J. Stern, MD,
    10. S. C. Schachter, MD,
    11. D. Bergen, MD,
    12. D. Hirtz, MD,
    13. G. D. Montouris, MD,
    14. M. Nespeca, MD,
    15. B. Gidal, PharmD,
    16. W. J. Marks Jr., MD,
    17. W. R. Turk, MD,
    18. J. H. Fischer, MD,
    19. B. Bourgeois, MD,
    20. A. Wilner, MD,
    21. R. E. Faught Jr., MD,
    22. R. C. Sachdeo, MD,
    23. A. Beydoun, MD and
    24. T. A. Glauser, MD
  1. J. A. French, MD*,
  2. A. M. Kanner, MD†,
  3. J. Bautista, MD,
  4. B. Abou-Khalil, MD,
  5. T. Browne, MD,
  6. C. L. Harden, MD,
  7. W. H. Theodore, MD,
  8. C. Bazil, MD PhD,
  9. J. Stern, MD,
  10. S. C. Schachter, MD,
  11. D. Bergen, MD,
  12. D. Hirtz, MD,
  13. G. D. Montouris, MD,
  14. M. Nespeca, MD,
  15. B. Gidal, PharmD,
  16. W. J. Marks Jr., MD,
  17. W. R. Turk, MD,
  18. J. H. Fischer, MD,
  19. B. Bourgeois, MD,
  20. A. Wilner, MD,
  21. R. E. Faught Jr., MD,
  22. R. C. Sachdeo, MD,
  23. A. Beydoun, MD and
  24. T. A. Glauser, MD
  1. From the University of Pennsylvania (Dr. French), Philadelphia; Department of Neurological Sciences (Drs. Kanner and Bergen), Rush Medical College, Chicago, IL; The Cleveland Clinic Foundation (Dr. Bautista), OH; Vanderbilt University Medical Center (Dr. Abou-Khalil), Nashville, TN; Boston University Medical Center (Drs. Browne and Montouris), MA; Weill Medical College of Cornell University (Dr. Harden), New York, NY; National Institutes of Neurological Disorders and Stroke (Drs. Theodore and Hirtz), National Institutes of Health, Bethesda, MD; Columbia Presbyterian Medical Center (Dr. Bazil), New York, NY; Beth Israel Deaconess Medical Center and Harvard Medical School (Drs. Stern and Schachter), Boston, MA; Children’s Hospital San Diego (Dr. Nespeca), CA; School of Pharmacy and Department of Neurology (Dr. Gidal), University of Wisconsin Hospital and Clinics, Madison; University of California San Francisco Epilepsy Center (Dr. Marks), CA; Nemours Children’s Clinic Div. of Neurology (Dr. Turk), Jacksonville, FL; University of Illinois College of Pharmacy (Dr. Fischer), Dept. of Pharmacy Practice and Neurology, Colleges of Pharmacy and Medicine, Chicago; Department of Neurology (Dr. Bourgeois), Children’s Hospital, Boston, MA; Private practice (Dr. Wilner), Providence, RI; Department of Neurology (Dr. Faught), University of Alabama School of Medicine, Birmingham; Dept. of Neurology (Dr. Sachdeo), University of Medicine and Dentistry of New Jersey, New Brunswick; Dept. of Neurology (Dr. Beydoun), University of Michigan, Ann Arbor; and Dept. of Neurology (Dr. Glauser), Children’s Hospital Medical Center, Cincinnati, OH.
  1. Address correspondence and reprint requests to TTA and QSS subcommittees, American Academy of Neurology, 1080 Montreal Ave., St. Paul, MN 55116
View Full Text

Article usage

Article usage: April 2004 to April 2020

AbstractFullPdfSource
Apr 20043385141495Highwire
May 200442012573133Highwire
Jun 20041254521485Highwire
Jul 2004108333985Highwire
Aug 200492225850Highwire
Sep 200468189807Highwire
Oct 200463175629Highwire
Nov 200453345789Highwire
Dec 200457281569Highwire
Jan 200552418818Highwire
Feb 200543364673Highwire
Mar 200551366843Highwire
Apr 200529294632Highwire
May 200533263602Highwire
Jun 200537222483Highwire
Jul 200524206481Highwire
Aug 2005204769562Highwire
Sep 200532309567Highwire
Oct 200538345541Highwire
Nov 200532209556Highwire
Dec 200532140456Highwire
Jan 200627197466Highwire
Feb 200630176536Highwire
Mar 200664200500Highwire
Apr 200622166632Highwire
May 200620179492Highwire
Jun 200624147363Highwire
Jul 200618121386Highwire
Aug 200633162420Highwire
Sep 200627200452Highwire
Oct 200623214452Highwire
Nov 200618154402Highwire
Dec 20068120232Highwire
Jan 20079119352Highwire
Feb 200719141372Highwire
Mar 200731160416Highwire
Apr 200726154390Highwire
May 200716138269Highwire
Jun 200736110234Highwire
Jul 200730110245Highwire
Aug 200726109240Highwire
Sep 200733124237Highwire
Oct 200730196310Highwire
Nov 200716108310Highwire
Dec 20071898301Highwire
Jan 20083284314Highwire
Feb 20081292327Highwire
Mar 200822105337Highwire
Apr 200810107296Highwire
May 200831120314Highwire
Jun 200815104306Highwire
Jul 200824112275Highwire
Aug 20081094225Highwire
Sep 200816120257Highwire
Oct 200821149323Highwire
Nov 20081983329Highwire
Dec 20082563291Highwire
Jan 2009956306Highwire
Feb 20091573336Highwire
Mar 200920119412Highwire
Apr 200922100338Highwire
May 200917114362Highwire
Jun 20092198319Highwire
Jul 20094486287Highwire
Aug 20093297342Highwire
Sep 20093495331Highwire
Oct 200974151413Highwire
Nov 20092899346Highwire
Dec 200934144308Highwire
Jan 201040150375Highwire
Feb 201039195453Highwire
Mar 201053161460Highwire
Apr 20106585351Highwire
May 20106174305Highwire
Jun 20105275268Highwire
Jul 20104075290Highwire
Aug 201056118307Highwire
Sep 201046123298Highwire
Oct 201075126371Highwire
Nov 20102029100Highwire
Dec 20107486266Highwire
Jan 20119167308Highwire
Feb 20115787314Highwire
Mar 201175114438Highwire
Apr 20118764348Highwire
May 20117070300Highwire
Jun 20117869326Highwire
Jul 20119454293Highwire
Aug 20117783388Highwire
Sep 201182112336Highwire
Oct 201192103417Highwire
Nov 201110969446Highwire
Dec 20119068326Highwire
Jan 20129979351Highwire
Feb 201211167433Highwire
Mar 2012161100453Highwire
Apr 2012136146473Highwire
May 201212171460Highwire
Jun 20129685325Highwire
Jul 20129962382Highwire
Aug 20129380403Highwire
Sep 20127462422Highwire
Oct 20129484637Highwire
Nov 20128785534Highwire
Dec 20128255392Highwire
Jan 201310684512Highwire
Feb 2013136196637Highwire
Mar 2013104113437Highwire
Apr 201313599621Highwire
May 20139478517Highwire
Jun 20139340496Highwire
Jul 201311051549Highwire
Aug 201310753666Highwire
Sep 201314242630Highwire
Oct 201312263799Highwire
Nov 201312672683Highwire
Dec 2013490129478Highwire
Jan 2014264205483Highwire
Feb 2014171271489Highwire
Mar 2014176280559Highwire
Apr 2014139262210Highwire
May 2014125215201Highwire
Jun 2014100208188Highwire
Jul 2014129224237Highwire
Aug 201487196230Highwire
Sep 2014116257254Highwire
Oct 2014102274278Highwire
Nov 2014137324304Highwire
Dec 201479202224Highwire
Jan 201594242244Highwire
Feb 2015147287270Highwire
Mar 2015149273238Highwire
Apr 201598235212Highwire
May 201566252197Highwire
Jun 201572236226Highwire
Jul 201592232180Highwire
Aug 201582229229Highwire
Sep 201587259197Highwire
Oct 201584259169Highwire
Nov 2015114271180Highwire
Dec 201590218167Highwire
Jan 201685288233Highwire
Feb 201698202223Highwire
Mar 2016134221214Highwire
Apr 201678205223Highwire
May 201679198177Highwire
Jun 201656172158Highwire
Jul 201665180144Highwire
Aug 201662185174Highwire
Sep 2016234241148Highwire
Oct 2016222222162Highwire
Nov 2016247230164Highwire
Dec 2016149167163Highwire
Jan 2017198253199Highwire
Feb 2017238280114Highwire
Mar 2017236284143Highwire
Apr 2017230243128Highwire
May 201721616493Highwire
Jun 20179715584Highwire
Jul 20179016982Highwire
Aug 20178525581Highwire
Sep 201744209116Highwire
Oct 2017113219125Highwire
Nov 201785312121Highwire
Dec 20172112672Highwire
Jan 20183713578Highwire
Feb 20186010969Highwire
Mar 201866124100Highwire
Apr 20184911264Highwire
May 2018389750Highwire
Jun 20184811287Highwire
Jul 20183211671Highwire
Aug 20183016376Highwire
Sep 20182512669Highwire
Oct 20182116475Highwire
Nov 20181716367Highwire
Dec 20181416843Highwire
Jan 20191414564Highwire
Feb 20191614277Highwire
Mar 20191910777Highwire
Apr 2019169374Highwire
May 2019148560Highwire
Jun 201979938Highwire
Jul 2019147653Highwire
Aug 201989258Highwire
Sep 20191011749Highwire
Oct 20191631475Highwire
Nov 201949150Highwire
Dec 201956538Highwire
Jan 2020118643Highwire
Feb 202048633Highwire
Mar 2020811640Highwire
Apr 2020105135Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

  • Reply to Panayiotopoulos et al
    • Jacqueline French, TTA and QSS subcommittees, American Academy of Neurology, 1080 Montreal Ave., St. Paul, MN 55166
    Submitted September 15, 2004
  • Efficacy and tolerability of the new antiepileptic drugs: Commentary on the practice parameters
    • C.P. Panayiotopoulos, Dept. of Clinical Neurophysiology and Epilepsies, St. Thomas' Hospital, London SE1 7EH
    • Selim R. Benbadis, Athanasios Covanis, Olivier Dulac, John S. Duncan, Orvar Eeg-Olofsson, Colin D. Ferrie, Richard A. Grunewald, Dorothee G.A. Kasteleijn-Nolst Trenite, Michael Koutroumanidis, Zarko Martinovic, Richard W. Newton, Alasdair P. Parker,
    Submitted September 15, 2004
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me